6533b870fe1ef96bd12cf3ff
RESEARCH PRODUCT
A bug in the resistance to EGFR inhibitors: is there a role for Mycoplasma and cytidine deaminase in reducing the activity of osimertinib in lung cancer patients?
Daniela CarboneDaniela CarboneElisa GiovannettiAlessandro GregoriDongmei DengGodefridus J. PetersMarcello TiseoAlessandro LeonettiAlessandro Leonettisubject
Cancer Researchmedicine.medical_specialtyLung Neoplasmsprotein p37monoclonal antibody pd4medicine.disease_causeMycoplasmaSDG 3 - Good Health and Well-beingInternal medicinemedicineHumansOsimertinibLung cancercytidine deaminaseEGFR inhibitorsAcrylamidesAniline CompoundsHematologybusiness.industrygemcitabineGeneral MedicineMycoplasmaCytidine deaminasemedicine.diseaseErbB ReceptorsOncologymonoclonal antibodyosimertinibCancer research/dk/atira/pure/sustainabledevelopmentgoals/good_health_and_well_beingbusinessyear | journal | country | edition | language |
---|---|---|---|---|
2021-10-01 |